| Childhood maltreatment and inflammatory markers: a systematic review R Coelho, TW Viola, C Walss‐Bass, E Brietzke, R Grassi‐Oliveira Acta Psychiatrica Scandinavica 129 (3), 180-192, 2014 | 428 | 2014 |
| Revisiting inflammation in bipolar disorder GR Fries, C Walss-Bass, ME Bauer, AL Teixeira Pharmacology Biochemistry and Behavior 177, 12-19, 2019 | 134 | 2019 |
| A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia C Walss-Bass, W Liu, DF Lew, R Villegas, P Montero, A Dassori, ... Biological psychiatry 60 (6), 548-553, 2006 | 127 | 2006 |
| Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway DH Dimitrov, S Lee, J Yantis, C Valdez, RM Paredes, N Braida, D Velligan, ... Schizophrenia research 151 (1-3), 29-35, 2013 | 123 | 2013 |
| Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder GR Fries, IE Bauer, G Scaini, MJ Wu, IF Kazimi, SS Valvassori, ... Translational psychiatry 7 (12), 1283, 2017 | 120 | 2017 |
| Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia I Chavarría‐Siles, J Contreras‐Rojas, E Hare, C Walss‐Bass, P Quezada, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147 …, 2008 | 112 | 2008 |
| Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder K Matsuo, C Walss-Bass, FG Nery, MA Nicoletti, JP Hatch, BN Frey, ... Neuropsychopharmacology 34 (8), 1904-1913, 2009 | 101 | 2009 |
| Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells V Contreras-Shannon, DL Heart, RM Paredes, E Navaira, G Catano, ... PloS one 8 (3), e59012, 2013 | 98 | 2013 |
| The β isotypes of tubulin in neuronal differentiation J Guo, C Walss‐Bass, RF Ludueña Cytoskeleton 67 (7), 431-441, 2010 | 93 | 2010 |
| The role of DNA methylation in the pathophysiology and treatment of bipolar disorder GR Fries, Q Li, B McAlpin, T Rein, C Walss-Bass, JC Soares, J Quevedo Neuroscience & Biobehavioral Reviews 68, 474-488, 2016 | 75 | 2016 |
| Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele B Cao, IE Bauer, AN Sharma, B Mwangi, T Frazier, L Lavagnino, ... Journal of affective disorders 198, 198-205, 2016 | 73 | 2016 |
| Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings K Marballi, D Cruz, P Thompson, C Walss-Bass PloS one 7 (5), e36431, 2012 | 71 | 2012 |
| In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation K Marballi, MP Quinones, F Jimenez, MA Escamilla, H Raventós, ... Journal of molecular medicine 88, 1133-1141, 2010 | 71 | 2010 |
| Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome RM Paredes, M Quinones, K Marballi, X Gao, C Valdez, SS Ahuja, ... International Journal of Neuropsychopharmacology 17 (8), 1139-1148, 2014 | 69 | 2014 |
| Accelerated hippocampal biological aging in bipolar disorder GR Fries, IE Bauer, G Scaini, SS Valvassori, C Walss‐Bass, JC Soares, ... Bipolar disorders 22 (5), 498-507, 2020 | 64 | 2020 |
| Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia C Walss-Bass, JM Fernandes, DL Roberts, H Service, D Velligan Schizophrenia research 147 (2-3), 387-392, 2013 | 62 | 2013 |
| Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations C Walss-Bass, ST Weintraub, J Hatch, J Mintz, AR Chaudhuri International Journal of Neuropsychopharmacology 11 (8), 1097-1104, 2008 | 58 | 2008 |
| The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia Q Li, X Du, Y Zhang, G Yin, G Zhang, C Walss-Bass, J Quevedo, ... Psychiatry research 251, 131-136, 2017 | 57 | 2017 |
| Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia G Scaini, J Quevedo, D Velligan, DL Roberts, H Raventos, C Walss-Bass European Neuropsychopharmacology 28 (3), 369-380, 2018 | 55 | 2018 |
| Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations MR Baig, E Navaira, MA Escamilla, H Raventos, C Walss-Bass Journal of Psychiatric Practice® 16 (5), 325-333, 2010 | 54 | 2010 |
